Drugs that may stop COVID-19 heart damage identified

Canadian company Resverlogix has already used the findings by the QIMR Berghofer Medical Research Institute as the basis for expanding a trial of its drug apabetalone into patients with COVID-19.In severe COVID-19 cases, the immune system over-reacts to the infection, releasing inflammatory molecules, known as cytokines, into the bloodstream.DEATH OR A SNIFFLE – QLD TEAM’S BID TO UNRAVEL COVID-19 EXTREMESQLD LAUNCHES NEEDLE-FREE COVID-19 VACCINE TRIALA so-called “cytokine storm” develops,…



Click here to view the original article.